Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Rosiglitazone (as rosiglitazone maleate) 8 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Rosiglitazone maleate 2mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Rosiglitazone maleate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely rosiglitazone maleate 2 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely glimepiride 1 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely glimepiride 2 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metformin hydrochloride 500 mg and rosiglitazone (as rosiglitazone maleate) 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 2 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Rosiglitazone (as rosiglitazone maleate) 8 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely rosiglitazone maleate 2 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely rosiglitazone maleate 2 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glimepiride 2 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely glimepiride 2 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Metformin hydrochloride 500 mg and rosiglitazone (as rosiglitazone maleate) 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 2 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely glimepiride 1 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely glimepiride 1 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Rosiglitazone (as rosiglitazone maleate) 8 mg oral tablet |
Has precise active ingredient |
True |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet |
Has precise active ingredient |
True |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glimepiride 2 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Metformin hydrochloride 500 mg and rosiglitazone (as rosiglitazone maleate) 2 mg oral tablet |
Has precise active ingredient |
False |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 2 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely rosiglitazone maleate 2 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glimepiride 1 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Metformin hydrochloride 500 mg and rosiglitazone (as rosiglitazone maleate) 2 mg oral tablet |
Has precise active ingredient |
True |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely glimepiride 2 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glimepiride 2 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glimepiride 1 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glimepiride 1 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glimepiride 4 milligram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Glimepiride 2 mg and rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet |
Has precise active ingredient |
True |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Glimepiride 1 mg and rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet |
Has precise active ingredient |
True |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely rosiglitazone (as rosiglitazone maleate) 2 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glimepiride 2 milligram and rosiglitazone (as rosiglitazone maleate) 8 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Glimepiride 4 mg and rosiglitazone (as rosiglitazone maleate) 8 mg oral tablet |
Has precise active ingredient |
True |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Rosiglitazone maleate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |